This inventor holds 3 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1999-2000.
Company Filing History:
Years Active: 1999-2000
Title: The Innovations of Arthur Campfield
Introduction
Arthur Campfield is a notable inventor based in Verona, NJ (US), recognized for his contributions to the field of obesity treatment through innovative protein compositions. With a total of three patents to his name, Campfield has made significant strides in developing solutions aimed at modulating body weight in both animals and humans.
Latest Patents
Campfield's latest patents include groundbreaking work on pegylated obese (ob) protein compositions. These compositions involve polyethylene and polypropylene protein conjugates that are designed to modulate body weight, providing treatment, prevention, and control of obesity and associated diseases or conditions. His research also focuses on the recombinant expression of these biologically active proteins in purified and homogeneous forms, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Campfield has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has not only contributed to the company's innovative portfolio but has also positioned him as a key figure in the fight against obesity.
Collaborations
Campfield has collaborated with esteemed colleagues such as Rene Devos and Yves Guisez, further enhancing the impact of his research and innovations in the field.
Conclusion
Arthur Campfield's work exemplifies the intersection of innovation and healthcare, particularly in addressing obesity through scientific advancements. His contributions continue to influence the development of effective treatments for this pressing health issue.